ETFs positioned on West Pharmaceutical Services, Inc.

Name YTD change Weight AuM
+13.42%-.--% 44,934 M€
+14.60%-.--% 750 M€
+14.95%-.--% 37 M€
+11.17%-.--% 67 M€
+13.49%-.--% 27,154 M€
+11.06%-.--% 122 M€
+7.79%-.--% 148 M€
+11.98%-.--% 1,251 M€
+15.78%-.--% 1,674 M€
+14.42%-.--% 3 M€
+14.06%-.--% 2,303 M€
+11.33%-.--% 44 M€
+18.05%1.5% 792 M€
+11.39%1.41% 11,905 M€
+16.70%1.39% 8 M€
+9.24%1.36% 12,285 M€
-.--%1.36% 42 M€
+3.37%1.29% 54 M€
+13.34%1.24% 131 M€
-9.23%1.2% 641 M€
+13.52%1.02% 13 M€
+10.26%1.02% 61 M€
-.--%0.95% 2 M€
+6.63%0.79% 56 M€
+23.47%0.74% 2,036 M€
+15.21%0.7% 62 M€
+11.78%0.62% 75 M€
+11.92%0.6% 106 M€
Logo West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and administration of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by group of products as follows: - proprietary products (81.1%); - contract-manufactured products (18.9%). At the end of 2025, the group had 25 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (43.2%), Germany (12.4%), Ireland (10.8%), France (7.4%), Europe (14.7%) and other (11.5%).
Employees
10,800
  1. Stock Market
  2. Stocks
  3. WST Stock
  4. ETFs West Pharmaceutical Services, Inc.